CN105777781B - 具有荧光功能的噻唑[4,5‑e]噻吩[2,3‑b]吡啶类衍生物及其制备方法 - Google Patents
具有荧光功能的噻唑[4,5‑e]噻吩[2,3‑b]吡啶类衍生物及其制备方法 Download PDFInfo
- Publication number
- CN105777781B CN105777781B CN201610217382.2A CN201610217382A CN105777781B CN 105777781 B CN105777781 B CN 105777781B CN 201610217382 A CN201610217382 A CN 201610217382A CN 105777781 B CN105777781 B CN 105777781B
- Authority
- CN
- China
- Prior art keywords
- compound
- arh
- hydroxyl
- reaction
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 title claims abstract description 34
- 229930192474 thiophene Natural products 0.000 title claims abstract description 17
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 150000003222 pyridines Chemical class 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 114
- -1 methoxyl group Chemical group 0.000 claims abstract description 25
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000460 chlorine Chemical group 0.000 claims abstract description 8
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 5
- 239000001257 hydrogen Substances 0.000 claims abstract description 5
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims abstract description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 4
- 239000011737 fluorine Chemical group 0.000 claims abstract description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 3
- 238000006243 chemical reaction Methods 0.000 claims description 43
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 33
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 24
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 20
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 15
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 8
- 239000005864 Sulphur Substances 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 7
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 7
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 7
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 7
- ZJRCIQAMTAINCB-UHFFFAOYSA-N benzoylacetonitrile Chemical group N#CCC(=O)C1=CC=CC=C1 ZJRCIQAMTAINCB-UHFFFAOYSA-N 0.000 claims description 7
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 7
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000002585 base Substances 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 4
- 239000002798 polar solvent Substances 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 238000006467 substitution reaction Methods 0.000 claims description 4
- OBOSXEWFRARQPU-UHFFFAOYSA-N 2-n,2-n-dimethylpyridine-2,5-diamine Chemical compound CN(C)C1=CC=C(N)C=N1 OBOSXEWFRARQPU-UHFFFAOYSA-N 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- 229910021595 Copper(I) iodide Inorganic materials 0.000 claims description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- OQRMRSDZEJMEHR-UHFFFAOYSA-N acetic acid;scandium Chemical compound [Sc].CC(O)=O OQRMRSDZEJMEHR-UHFFFAOYSA-N 0.000 claims description 3
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims description 3
- VYLVYHXQOHJDJL-UHFFFAOYSA-K cerium trichloride Chemical compound Cl[Ce](Cl)Cl VYLVYHXQOHJDJL-UHFFFAOYSA-K 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- CZKMPDNXOGQMFW-UHFFFAOYSA-N chloro(triethyl)germane Chemical compound CC[Ge](Cl)(CC)CC CZKMPDNXOGQMFW-UHFFFAOYSA-N 0.000 claims description 3
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 229940099596 manganese sulfate Drugs 0.000 claims description 3
- 239000011702 manganese sulphate Substances 0.000 claims description 3
- 235000007079 manganese sulphate Nutrition 0.000 claims description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 3
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- NGOCMUBXJDDBLB-UHFFFAOYSA-N trifluoromethanesulfonic acid;zinc Chemical compound [Zn].OS(=O)(=O)C(F)(F)F NGOCMUBXJDDBLB-UHFFFAOYSA-N 0.000 claims description 3
- 239000004246 zinc acetate Substances 0.000 claims description 3
- 239000011592 zinc chloride Substances 0.000 claims description 3
- 235000005074 zinc chloride Nutrition 0.000 claims description 3
- RXBXBWBHKPGHIB-UHFFFAOYSA-L zinc;diperchlorate Chemical compound [Zn+2].[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O RXBXBWBHKPGHIB-UHFFFAOYSA-L 0.000 claims description 3
- DUNKXUFBGCUVQW-UHFFFAOYSA-J zirconium tetrachloride Chemical compound Cl[Zr](Cl)(Cl)Cl DUNKXUFBGCUVQW-UHFFFAOYSA-J 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- SVOOVMQUISJERI-UHFFFAOYSA-K rhodium(3+);triacetate Chemical compound [Rh+3].CC([O-])=O.CC([O-])=O.CC([O-])=O SVOOVMQUISJERI-UHFFFAOYSA-K 0.000 claims description 2
- 238000007363 ring formation reaction Methods 0.000 claims description 2
- QUJLPICXDXFRSN-UHFFFAOYSA-N scandium;trifluoromethanesulfonic acid Chemical compound [Sc].OS(=O)(=O)C(F)(F)F QUJLPICXDXFRSN-UHFFFAOYSA-N 0.000 claims description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 2
- 229960001763 zinc sulfate Drugs 0.000 claims description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 2
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 claims 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical group [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 claims 1
- 238000010511 deprotection reaction Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 7
- 229910052740 iodine Inorganic materials 0.000 abstract description 3
- 239000011630 iodine Substances 0.000 abstract description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 abstract 1
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 abstract 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 64
- 230000015572 biosynthetic process Effects 0.000 description 35
- 239000007787 solid Substances 0.000 description 35
- 238000003786 synthesis reaction Methods 0.000 description 35
- 238000005160 1H NMR spectroscopy Methods 0.000 description 34
- 238000010189 synthetic method Methods 0.000 description 29
- 235000019441 ethanol Nutrition 0.000 description 8
- 239000007788 liquid Substances 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 150000002391 heterocyclic compounds Chemical class 0.000 description 3
- WZUODJNEIXSNEU-UHFFFAOYSA-N 2-Hydroxy-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(O)=C1 WZUODJNEIXSNEU-UHFFFAOYSA-N 0.000 description 2
- YGHRJJRRZDOVPD-UHFFFAOYSA-N 3-methylbutanal Chemical compound CC(C)CC=O YGHRJJRRZDOVPD-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- 0 CC(C)c1cc(C(c2c(*)cccc2)=NCC(N2)=O)c2[s]1 Chemical compound CC(C)c1cc(C(c2c(*)cccc2)=NCC(N2)=O)c2[s]1 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- UMRSVAKGZBVPKD-UHFFFAOYSA-N acetic acid;copper Chemical compound [Cu].CC(O)=O UMRSVAKGZBVPKD-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N methyl cyanide Natural products CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- WXSGQHKHUYTJNB-UHFFFAOYSA-N 2,6-dimethoxybenzaldehyde Chemical class COC1=CC=CC(OC)=C1C=O WXSGQHKHUYTJNB-UHFFFAOYSA-N 0.000 description 1
- CWKMIEALBOKDCD-UHFFFAOYSA-N 2-(benzenesulfonyl)benzaldehyde Chemical compound O=CC1=CC=CC=C1S(=O)(=O)C1=CC=CC=C1 CWKMIEALBOKDCD-UHFFFAOYSA-N 0.000 description 1
- FXWFZIRWWNPPOV-UHFFFAOYSA-N 2-aminobenzaldehyde Chemical class NC1=CC=CC=C1C=O FXWFZIRWWNPPOV-UHFFFAOYSA-N 0.000 description 1
- KQBUUAMEELZUED-UHFFFAOYSA-N 2-chloro-3-oxo-3-phenylpropanenitrile Chemical group N#CC(Cl)C(=O)C1=CC=CC=C1 KQBUUAMEELZUED-UHFFFAOYSA-N 0.000 description 1
- RRIQVLZDOZPJTH-UHFFFAOYSA-N 3,5-di-tert-butyl-2-hydroxybenzaldehyde Chemical class CC(C)(C)C1=CC(C=O)=C(O)C(C(C)(C)C)=C1 RRIQVLZDOZPJTH-UHFFFAOYSA-N 0.000 description 1
- MKKSTJKBKNCMRV-UHFFFAOYSA-N 5-bromo-2-hydroxybenzaldehyde Chemical class OC1=CC=C(Br)C=C1C=O MKKSTJKBKNCMRV-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 101150050192 PIGM gene Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- NENDHUHGFRLXEN-UHFFFAOYSA-N acetic acid;rhodium Chemical compound [Rh].CC(O)=O NENDHUHGFRLXEN-UHFFFAOYSA-N 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- YMNKUHIVVMFOFO-UHFFFAOYSA-N anthracene-9-carbaldehyde Chemical class C1=CC=C2C(C=O)=C(C=CC=C3)C3=CC2=C1 YMNKUHIVVMFOFO-UHFFFAOYSA-N 0.000 description 1
- 239000012296 anti-solvent Substances 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006462 rearrangement reaction Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 150000003557 thiazoles Chemical class 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1092—Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
本发明提供了一类如式(I)所示的噻唑[4,5‑e]噻吩[2,3‑b]吡啶类化合物,其作为具有荧光功能的化合物的应用,并提供了其制备方法:
Description
技术领域
本发明涉及一类具有荧光功能的有机小分子,具体涉及一类新型的噻唑[4,5-e]噻吩[2,3-b]吡啶类衍生物及其制备方法,它们同时具有强的液体荧光和固体荧光。
背景技术
大约50%的有机化合物在结构上属于杂环化合物(Palwinder Singh.ExpertOpin.Ther.Pat.2011,21(4):437-454),由于杂环化合物的结构独特,是近年来开发新型有机光电材料的基本骨架(Angew Chem Int Ed Engl 2014,53(9):2290-310)。因此,设计、合成结构新颖的杂环化合物并研究它们在材料科学特别是有机发光材料方面的应用具有重要的科学意义和应用价值(Acc Chem Res 2012,45(8):1278-93)。
作为传统的有机小分子发光材料,吩噻嗪类化合物呈现蝴蝶型构型,在太阳能敏化电池(Eur.J.Org.Chem.2014,32:7069-7086)、锂离子电池(J.Phys.Chem.C 2014,118(27):14824-14832)、光催化产氢(J.Mater.Chem.A 2014,2(32):12952-12961)、非线性光学材(Chem.-Eur.J.2008,14(8):2602-2614)、延迟荧光材料(Angew Chem Int Ed Engl2015,54(3):874-8)、有机发光二极管(Angew.Chem.Int.Ed.2014,53(8):2119-23)、聚合物发光二极管(Chem.-Eur.J.2008,14(8):2602-2614)、分子线(J.Am.Chem.Soc.2005,127(33):11842-11850)等方面获得了独特的应用(染料与染色2010,47(3):35-41)。另一类重要的吖啶类化合物,具有π共轭的平面结构,在染料、荧光探针及发光二极管等有机发光材料领域也有重要作用(WO2013093481A1,2013;J.Lumin.2013,139:16-21;Dyes Pigm.2014,109:169-174;Adv.Opt.Mater.2014,2(9):892-901)。近年来报道的噻咯类化合物(Chem.Commun.2001,(18):1740-1741),四苯乙烯类化合物(J.Mater.Chem.2012,22(15):7515-7528;J.Mater.Chem.C 2015,3(11):2624-2631;Chem.Sci.2015,6(3):1932-1937;Chem.-Eur.J.2014,20(18):5317-5326),三芳胺类化合物(Aust.J.Chem.2012,65(4):387-394;Chem.-Eur.J.2011,17(9):2647-2655;Chem.Commun.2010,46(26):4689-4691),都具有良好的聚集诱导发光(AIE)性能,在有机发光二极管、化学传感器、生物传感器等方面具有良好的应用前景。
最近,本课题组通过重排反应,开发了一种新型的噻唑[4,5-e]噻吩[2,3-b]吡啶类化合物的合成方法(Synthesis 2014,46,2317-2326.)。通过对噻唑[4,5-e]噻吩[2,3-b]吡啶类化合物进行结构改造,得到一系列具有新型骨架结构的具有荧光功能的有机小分子,并且该类型的有机小分子发光材料未见文献报道。
本发明是在国家自然科学基金(21272287)和广东省重大科技专项基金(2012A080201007)资助下而进行的研究。
发明内容
本发明的目的是提供一类噻唑[4,5-e]噻吩[2,3-b]吡啶类化合物,其作为具有荧光功能的化合物的应用,并提供了其制备方法。
本发明是通过以下技术方案予以实现的:
本发明提供了如式(I)所示结构的噻唑[4,5-e]噻吩[2,3-b]吡啶类化合物:
其中,R选自氢,氯,氟。
R’选自4-羟基;2-羟基;2-甲基;2,6-二甲氧基;2-羟基-5-碘;2-羟基-5-溴;2-羟基-3,5-二叔丁基;2-羟基-4-氰基;2-羟基-4-甲氧基;2-羟基-5-磺酸基;2-氨基;2-甲磺酰胺基;2-对甲基苯磺酰胺基;2-对甲基苯磺酸酯基;2-(萘-2-磺酰胺基);4-苯磺酰基。
本发明的化合物噻唑[4,5-e]噻吩[2,3-b]吡啶类化合物的制备方法,包括以下步骤:
(1)以邻位取代的苯甲酰乙腈,异戊醛和硫粉为原料,在碱性条件下,以乙醇作溶剂,在回流状态下反应得到化合物(M1);所述邻位取代的苯甲酰乙腈、异戊醛、硫粉、碱的摩尔比为1:(1-5):(1-5):(1-5);邻位取代的苯甲酰乙腈的浓度为1-10mol/L。
所述的碱可以为有机碱,如三乙胺、吡啶或者吗啡啉等。
(2)以化合物(M1)和邻苯二甲酰甘氨酸为原料,以二氯甲烷作溶剂,EDCI和DMAP作脱水剂,在室温条件下反应得到化合物(M2);所述化合物(M1)、邻苯二甲酰甘氨酸为、EDCI、DMAP的摩尔比为1:(1-5):(1-5):(1-5);化合物(M2)的浓度为1-10mol/L。
(3)化合物(M2)在水合肼和浓盐酸作用下,以乙醇作溶剂,在0-80℃条件下,脱保护得到化合物(M3);所述化合物(M2)、水合肼、盐酸的摩尔比为1:(1-5):(1-5);化合物(M2)的浓度为1-10mol/L。
(4)化合物(M3)在酸性条件下,以醇类化合物作为反应溶剂,回流状态下关环得到化合物(M4);所述酸为盐酸、甲酸或乙酸,醇类溶剂为甲醇、乙醇或异丙醇;所述化合物(M3)、酸的摩尔比为1:(1-5);化合物(M3)的浓度为1-10mol/L。
(5)以化合物(M4)和五硫化二磷为原料,以甲苯为溶剂,在回流状态下反应得到化合物(M5);所述化合物(M4)、五硫化二磷的摩尔比为1:(1-5);化合物(M4)的浓度为1-10mol/L。
(6)将化合物(M5)和芳香醛类化合物,在催化剂存在的条件下,以极性溶剂作为反应溶剂,在80-200℃条件下,反应得到目标化合物(F);所述催化剂来源广泛,可以为醋酸铜、碘化亚铜、对甲苯磺酸、醋酸钠、氯化锌、三氟甲磺酸锌、硫酸锌、醋酸锌、高氯酸锌、醋酸铑、氯化铈、氯化钇、硫酸锰、氯化锂、氯化锆、苯硼酸、三氟甲磺酸银、三氟甲磺酸抗、醋酸钪;所述极性溶剂可以为:DMF、DMSO或NMP;所述化合物(M5)、芳香醛类化合物、催化剂的摩尔比为:1:(1-5):(0.01-1);化合物(M5)的浓度为1-10mol/L。
本发明还提供了所述噻唑[4,5-e]噻吩[2,3-b]吡啶类化合物作为具有荧光功能的化合物的应用。具体来说指其作为具有强的固体荧光和液体荧光功能的有机小分子的应用。其具有强的固体荧光和液体荧光功能,可望在有机光电器件、生物成像和生物传感器等方面有一定的应用。
本发明化合物是一类未见文献报道的具有新型结构骨架的荧光有机小分子,并且同时具有液体荧光和固体荧光。
具体实施方式
下面通过实施例来对本发明做进一步说明。
一、仪器与药品
本发明的核磁图谱(NMR)由德国Bruker公司生产的AVANCE 400仪器测定,溶剂峰做内标;本发明的质谱由日本岛津公司生产的LCMS-2010A(ESI源)和Thermo DSQ质谱仪(EI源)测定;化学试剂购自广州铭旺生物科技有限公司,北京伊诺凯科技有限公司,韶远科技(上海)有限公司,阿拉丁试剂(上海)有限公司等;柱层析用硅胶购自青岛海洋化工厂。
二、化合物结构式
三、实施例子
实施例1:化合物M1-1的合成
将苯甲酰乙腈(1.45g,10mmol),硫粉(960mg,30mmol),异戊醛(860mg,10mmol),吗啡啉(4350mg,50mmol),无水乙醇(10mL),在回流状态下反应;反应结束后冷至室温,加入乙酸乙酯,分别以水和饱和氯化钠溶液洗涤有机相,无水硫酸钠干燥,过滤,浓缩,用快速柱层析分离纯化,得到黄色油状物1.8g,收率75%。MS(EI):m/z(%)=245(55)M+,230(100);1HNMR(300MHz,CDCl3):δ=7.67-7.64(m,2H,ArH),7.50-7.40(m,3H,ArH),6.93(br s,2H,NH2),6.51(s,1H,ArH),2.92(sept,J=6.8Hz,1H,CH),1.23(d,J=6.8Hz,6H,2CH3)。
实施例2:化合物M1-2的合成
合成方法如实施例1,邻氟苯甲酰乙腈(1.63g,10mmol),硫粉(1.6g,50mmol),异戊醛(2.58g,30mmol),吡啶(1.58g,20mmol),无水乙醇(80mL),分离纯化得到黄色油状物1.65g,收率63%。MS(EI):m/z(%)=263(45)M+,248(100),228(38),152(37);1H NMR(400MHz,CDCl3)δ7.52–7.40(m,,2H),7.26–7.20(m,1H),7.20–7.11(m,1H),6.28(d,J=1.5Hz,1H),2.94–2.83(m,1H),1.22(d,J=6.8Hz,6H)。实施例3:化合物M1-3的合成
合成方法如实施例1,邻氯苯甲酰乙腈(1.8g,10mmol),硫粉(320mg,10mmol),异戊醛(4.3g,50mmol),三乙胺(1.01g,10mmol),无水乙醇(100mL),分离纯化得到黄色油状物2.2g,收率78%。MS(ESI+)m/z:302(M+Na+),334(M+MeOH+Na+);1H NMR(300MHz,CDCl3):δ=7.44-7.38(m,1H,ArH),7.37-7.27(m,3H,ArH),6.07-5.92(m,3H,ArH,NH2),2.83(sept,J=6.8Hz,1H,CH),1.18(d,J=6.8Hz,6H,2CH3)。
实施例4:化合物M2-1的合成
将化合物M1-1(2.453g,10mmol),邻苯二甲酰甘氨酸(2.05g,10mmol)。EDCI(5.76g,30mmol),DMAP(6.1g,50mmol)和二氯甲烷(50mL),在室温条件下反应;反应结束后,加入二氯甲烷稀释,分别以水,饱和氯化钠溶液洗涤有机相,无水硫酸钠干燥,过滤,浓缩,用快速柱层析分离纯化,得到黄色固体3.89g,收率90%。MS(EI):m/z(%)=432(55)M+,230(100),160(70),245(65);1H NMR(300MHz,CDCl3):δ=12.33(br s,1H,NH),7.91-7.88(m,2H,ArH),7.75-7.72(m,2H,ArH),7.68-7.65(m,2H,ArH),7.56-7.44(m,3H,ArH),6.75(s,1H,ArH),4.68(s,2H,CH2),3.03(sept,J=6.8Hz,1H,CH),1.27(d,J=6.8Hz,6H,2CH3)。
实施例5:化合物M2-2的合成
合成方法如实施例4,化合物M1-2(2.633g,10mmol),邻苯二甲酰甘氨酸(6.15g,30mmol)。EDCI(9.6g,50mmol),DMAP(1.22g,10mmol)和二氯甲烷(10mL),分离纯化得到白色固体4.05g,收率90%。MS(EI):m/z(%)=450(20)M+,248(45),160(100);1H NMR(400MHz,CDCl3)δ12.29(s,1H),7.97–7.90(m,2H),7.80–7.75(m,2H),7.55–7.43(m,2H),7.27(d,J=7.5Hz,1H),7.18(t,J=9.1Hz,1H),6.55(d,J=1.6Hz,1H),4.71(s,2H),3.07–2.95(m,1H),1.26(d,J=6.9Hz,6H)。
实施例6:化合物M2-3的合成
合成方法如实施例4,化合物M1-3(2.798g,10mmol),邻苯二甲酰甘氨酸(10.25g,50mmol)。EDCI(1.92g,10mmol),DMAP(3.66g,30mmol)和二氯甲烷(100mL),分离纯化得到白色固得到淡黄色固体4.16g,收率89%。MS(ESI+)m/z:489(M+Na+),521(M+MeOH+Na+);1H NMR(400MHz,CDCl3):δ=12.24(br s,1H,NH),7.94-7.92(m,2H,ArH),7.78-7.76(m,2H,ArH),7.48-7.36(m,4H,ArH),6.37(s,1H,ArH),4.73(s,2H,CH2),2.98(sept,J=6.8Hz,1H,CH),1.24(d,J=6.8Hz,6H,2CH3)。
实施例7:化合物M3-1的合成
将化合物M2-1(4.325g,10mmol),搅拌下加入水合肼(80%,700mg,10mmol),无水乙醇(50mL),在0℃条件下反应,滴入浓盐酸(2.5mL,30mmol),继续反应;反应完成后,减压过滤,滤渣以乙醇洗涤。滤液以饱和的NaHCO3溶液中和至pH=7。除去乙醇,加入二氯甲烷溶解,分别以水,饱和氯化钠溶液洗涤有机相,无水硫酸钠干燥,过滤,浓缩,用快速柱层析分离纯化,得到黄色固体1.81g,收率60%。(EI):m/z(%)=302(10)M+,230(100);1H NMR(300MHz,CDCl3):δ=12.87(br s,1H,NH),7.74-7.71(m,2H,ArH),7.57-7.44(m,3H,ArH),6.77(s,1H,ArH),3.67(s,2H,CH2),3.08(sept,J=6.7Hz,1H,CH),1.97(br s,2H,NH2),1.31(d,J=6.8Hz,6H,2CH3)。
实施例8:化合物M3-2的合成
合成方法如实施例7,化合物M2-2(4.505g,10mmol),水合肼(80%,2.1g,30mmol),浓盐酸(4.2mL,50mmol),无水乙醇(100mL),反应温度80℃,分离纯化得到米白色固体2.95g,收率92%。MS(EI):m/z(%)=320(12)M+,248(100),123(58);1H NMR(400MHz,CDCl3)δ12.93(s,1H),7.57–7.47(m,2H),7.28(d,J=6.1Hz,1H),7.19(t,J=9.2Hz,1H),6.57(d,J=1.4Hz,1H),3.68(s,2H),3.13–2.96(m,1H),1.81(s,2H),1.30(d,J=6.8Hz,6H)。
实施例9:化合物M3-3的合成
合成方法如实施例7,化合物M2-3(4.669g,10mmol),水合肼(80%,3.5g,50mmol),浓盐酸(0.85mL,10mmol),无水乙醇(10mL),反应温度50℃,分离纯化得到米白色固体3.03g,收率90%。MS(ESI+)m/z:337(M+H+),359(M+Na+),391(M+MeOH+Na+);1H NMR(400MHz,CDCl3):δ=12.88(br s,1H,NH),7.49-7.36(m,4H,ArH),6.38(s,1H,ArH),3.68(s,2H,CH2),3.00(sept,J=6.9Hz,1H,CH),1.27(d,J=6.9Hz,6H,2CH3)。
实施例10:化合物M4-1的合成
将化合物M3-1(3.024g,10mmol),盐酸(0.85mL,10mmol),甲醇(60mL),在回流状态下反应;反应完成后,冷至室温,加入二氯甲烷150mL,依次以饱和的NaHCO3溶液,水,饱和氯化钠溶液洗涤有机相,无水硫酸钠干燥,过滤,浓缩,用快速柱层析分离纯化,得到淡黄色固体1.73g,收率61%。MS(EI):m/z(%)=284(95)M+,255(100),241(50),149(60);1H NMR(300MHz,CDCl3):δ=10.53(br s,1H,NH),7.62-7.59(m,2H,ArH),7.42-7.34(m,3H,ArH),6.47(s,1H,ArH),4.42(s,2H,CH2),3.03(sept,J=6.7Hz,1H,CH),1.27(d,J=6.8Hz,6H,2CH3)。
实施例11:化合物M4-2的合成
合成方法如实施例10,化合物M3-2(3.204g,10mmol),甲酸(1.9mL,50mmol),乙醇(100mL),分离纯化得到米白色固体1.78g,收率59%。MS(EI):m/z(%)=302(68)M+,273(100),259(52);1H NMR(400MHz,CDCl3)δ7.58–7.50(m,1H),7.50–7.41(m,1H),7.27–7.18(m,1H),7.12(t,J=9.3Hz,1H),6.36(s,1H),4.49(s,2H),3.10–2.96(m,1H),1.28(d,J=6.8Hz,6H)。
实施例12:化合物M4-3的合成
合成方法如实施例10,化合物M3-3(3.368g,10mmol),乙酸(0.6mL,30mmol),异丙醇(10mL),分离纯化得到米白色固体1.94g,收率61%。MS(ESI+)m/z:319(M+H+),341(M+Na+),373(M+MeOH+Na+);1H NMR(400MHz,CDCl3):δ=10.16(br s,1H,NH),7.46-7.32(m,4H,ArH),6.21(s,1H,ArH),4.51(s,2H,CH2),2.99(sept,J=6.8Hz,1H,CH),1.25(d,J=6.8Hz,6H,2CH3)。
实施例13:化合物M5-1的合成
将化合物M4-1(2.844g,10mmol),五硫化二磷(1.91g,10mmol),甲苯(10mL),在回流状态下反应;反应结束后,旋转蒸发仪除去溶剂,加入饱和的NaHCO3,搅拌过夜,过滤,滤渣用快速柱层析分离纯化得到黄色固体2.76g,收率92%。MS(EI):m/z(%)=300(75)M+,299(100);1H NMR(300MHz,CDCl3):δ=7.61-7.59(m,2H,ArH),7.46-7.39(m,3H,ArH),6.52(s,1H,ArH),4.83(s,2H,CH2),3.06(sept,J=6.9Hz,1H,CH),1.30(d,J=6.7Hz,6H,2CH3)。
实施例14:化合物M5-2的合成
合成方法如实施例13,化合物M4-2(3.024g,10mmol),五硫化二磷(9.55g,50mmol),甲苯(100mL),分离纯化得到黄色固体2.85g,收率90%。MS(EI):m/z(%)=317(100)M+,299(42);1H NMR(400MHz,CDCl3)δ7.60–7.42(m,2H),7.26–7.07(m,2H),6.40(s,1H),4.91(s,2H),3.12–2.98(m,1H),1.29(d,J=6.5Hz,6H)。
实施例15:化合物M5-3的合成
合成方法如实施例13,化合物M4-3(3.188g,10mmol),五硫化二磷(5.73g,30mmol),甲苯(50mL),分离纯化得到黄棕色固体3.01g,收率90%。MS(ESI+)m/z:335(M+H+),357(M+Na+),389(M+MeOH+Na+);1H NMR(400MHz,DMSO-d6)δ13.21(br s,1H,NH),7.53-7.45(m,4H,ArH),6.22(s,1H,ArH),4.70(s,2H,CH2),3.03(sept,J=6.8Hz,1H,CH),1.17(d,J=6.8Hz,6H,2CH3)。
实施例16:化合物F1的合成
将化合物M5-3(334mg,1mmol),对羟基苯甲醛(366mg,3mmol),醋酸铜(182mg,1mmol),NMP(5mL),在120℃条件下反应12小时;反应完成后,冷至室温,加入乙酸乙酯,依次以饱和的NH4Cl溶液,水,饱和氯化钠溶液洗涤有机相,无水硫酸钠干燥,浓缩,用快速柱层析分离纯化,得到白色固体350mg,收率80%,MS(ESI+)m/z:437(M+H+),459(M+Na+),477(M+K+),491(M+MeOH+Na+);1H NMR(300MHz,CDCl3):δ=7.86(d,J=8.7Hz,2H,ArH),7.61-7.58(m,1H,ArH),7.51-7.39(m,3H,ArH),6.83(d,J=8.7Hz,2H,ArH),6.70(s,1H,ArH),3.50(brs,1H,OH),3.20(sept,J=6.8Hz,1H,CH),1.38(d,J=6.8Hz,6H,2CH3)。
实施例17:化合物F2的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),2-氨基苯甲醛(121mg,1mmol),碘化亚铜(95mg,0.5mmol),DMF(1mL),反应温度150℃,得到黄色固体218mg,收率50%。MS(EI):m/z(%)=435(100)M+,437(40)[M+2]+,420(95),400(40);1H NMR(400MHz,CDCl3):δ=7.72-7.70(m,1H,ArH),7.65-7.62(m,1H,ArH),7.56-7.54(m,1H,ArH),7.51-7.44(m,2H,ArH),7.24-7.20(m,1H,ArH),6.77-6.71(m,3H,ArH),3.24(sept,J=6.8Hz,1H,CH),1.42(d,J=6.8Hz,6H,2CH3)。
实施例18:化合物F3的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),2-甲基苯甲醛(600mg,5mmol),对甲苯磺酸(172mg,1mmol),DMSO(1mL),反应温度200℃,得到黄色固体325mg,收率75%。MS(EI):m/z(%)=434(80)M+,448(35)[M+2]+,419(85),399(100);1H NMR(400MHz,CDCl3):δ=7.80-7.77(m,1H,ArH),7.64-7.62(m,1H,ArH),7.55-7.53(m,1H,ArH),7.50-7.44(m,2H,ArH),7.37-7.31(m,3H,ArH),6.79(s,1H,ArH),3.26(sept,J=6.8Hz,1H,CH),2.62(s,3H,CH3),1.43(d,J=6.8Hz,6H,2CH3)。实施例19:化合物F4的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),对苯磺酰基苯甲醛(738mg,3mmol),醋酸钠(13.6mg,0.1mmol),DMF(5mL),反应温度80℃,得到黄色固体448mg,收率80%。MS(EI):m/z(%)=560(65)M+,562(30)[M+2]+,545(75),525(100);1H NMR(300MHz,CDCl3):δ=8.13-8.11(m,2H,ArH),8.01-7.92(m,4H,ArH),7.60-7.46(m,7H,ArH),6.73(s,1H,ArH),3.22(sept,J=7.1Hz,1H,CH),1.39(d,J=6.8Hz,6H,2CH3)。
实施例20:化合物F5的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),邻羟基苯甲醛(488mg,4mmol),氯化锌(1.4mg,0.01mmol),DMF(10mL),反应温度130℃,得到黄色固体270mg,收率62%。MS(EI):m/z(%)=436(95)M+,438(40)[M+2]+,421(100),401(50);1H NMR(400MHz,CDCl3):δ=12.09(br s,1H,OH),7.71-7.67(m,2H,ArH),7.55-7.48(m,3H,ArH),7.40-7.36(m,1H,ArH),7.04-6.95(m,2H,ArH),6.81(s,1H,ArH),3.25(sept,J=6.8Hz,1H,CH),1.42(d,J=6.9Hz,6H,2CH3)。
实施例21:化合物F6的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),2-对甲苯磺酰胺基苯甲醛(550mg,2mmol),三氟甲磺酸锌(18.2mg,0.05mmol),DMF(2mL),反应温度100℃,得到黄色固体342mg,收率58%。MS(EI):m/z(%)=589(62)M+,591(38)[M+2]+,434(100),418(80),382(35),91(95);1H NMR(400MHz,CDCl3)δ=11.63(brs,1H,NH),7.89–7.68(m,3H,ArH),7.61(m,3H.ArH),7.47–7.32(m,3H,ArH),7.16–7.02(m,3H,ArH),6.84(s,1H,ArH),3.35–3.19(m,1H,CH),2.29(s,3H,CH3),1.43(d,J=6.6Hz,6H,2CH3)。
实施例22:化合物F7的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),9-蒽甲醛(309mg,1.5mmol),硫酸锌(16.1mg,0.1mmol),DMSO(2mL),反应温度180℃,得到黄色固体374mg,收率72%。MS(EI):m/z(%)=520(100)M+;1H NMR(400MHz,CDCl3)δ8.61(s,1H,ArH),8.11–8.02(m,2H,ArH),7.99–7.92(m,2H,ArH),7.61–7.37(m,5H,ArH),6.81(s,1H,ArH),3.37–3.23(m,1H,CH),1.45(d,J=6.9Hz,6H,2CH3)。
实施例23:化合物F8的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),2,6-二甲氧基苯甲醛(581mg,3.5mmol),醋酸锌(55mg,0.3mmol),DMSO(8mL),反应温度170℃,得到黄色固体312mg,收率65%。MS MS(EI):m/z(%)=480(100)M+;1H NMR(400MHz,CDCl3)δ7.61–7.52(m,2H,ArH),7.47–7.40(m,2H,ArH),7.37(t,J=8.4Hz,1H,ArH),6.73(s,1H,ArH),6.64(d,J=8.4Hz,2H,ArH),3.81(s,6H,2OCH3),3.30–3.16(m,1H,CH),1.41(d,J=6.9Hz,6H,2CH3)。
实施例24:化合物F9的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),5-碘水杨醛(1166mg,4.5mmol),高氯酸锌(186mg,0.5mmol),DMSO(10mL),反应温度190℃,得到黄色固体326mg,收率58%。MS(EI):m/z(%)=562(100)M+,547(62),527(44);1H NMR(400MHz,CDCl3)δ7.95(s,1H,ArH),7.71–7.46(m,5H,ArH),6.84–6.77(m,2H,ArH),3.32–3.20(m,1H,CH),1.42(d,J=6.8Hz,6H,2CH3)。
实施例25:化合物F10的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),3,5-二叔丁基水杨醛(234mg,1mmol),醋酸铑(2.8mg,0.01mmol),DMSO(3mL),反应温度100℃,得到黄色固体367mg,收率67%。MS(EI):m/z(%)=548(100)M+;1H NMR(400MHz,CDCl3)δ7.71–7.66(m,1H,ArH),7.57–7.45(m,5H,ArH),6.78(s,1H,ArH),3.30–3.18(m,1H,CH),1.46–1.37(m,24H,8CH3)。
实施例26:化合物F11的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),4-甲酰基-3-羟基苯甲腈(735mg,5mmol),氯化铈(246mg,1mmol),NMP(2mL),反应温度130℃,得到黄色固体300mg,收率65%。MS(EI):m/z(%)=461(68)M+,463(28)[M+2]+,446(100),426(40),206(60);1H NMR(400MHz,CDCl3)δ12.38(s,1H,OH),7.83–7.65(m,2H,ArH),7.61–7.45(m,3H,ArH),7.34–7.19(m,2H,ArH),6.82(s,1H,ArH),3.47–3.08(m,1H,CH),1.43(d,J=5.6Hz,6H),2CH3。
实施例27:化合物F12的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),4-甲氧基水杨醛(456mg,3mmol),氯化钇(117mg,0.6mmol),NMP(5mL),反应温度120℃,得到黄色固体280mg,收率60%。MS(EI):m/z(%)=466(100)M+;1H NMR(400MHz,CDCl3)δ7.71–7.64(m,1H,ArH),7.59(d,J=8.7Hz,1H,ArH),7.55–7.46(m,3H,ArH),6.79(d,J=0.7Hz,1H,ArH),6.58–6.48(m,2H,ArH),3.85(s,3H,OCH3),3.31–3.20(m,1H,CH),1.42(d,J=6.8Hz,6H,2CH3)。
实施例28:化合物F13的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),3-甲酰基-4-羟基苯磺酸(404mg,2mmol),硫酸锰(45mg,0.3mmol),NMP(10mL),反应温度100℃,得到黄色固体300mg,收率58%。MS(ESI-)m/z:515(M-H)-;1H NMR(400MHz,DMSO-d6)δ8.28–8.20(m,1H,ArH),7.78–7.73(m,1H,ArH),7.67–7.57(m,4H,ArH),6.98(d,J=8.5Hz,1H,ArH),6.76(s,1H,ArH),3.31–3.20(m,1H,CH),1.33(d,J=6.8Hz,6H,2CH3).实施例29:化合物F14的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),5-溴水杨醛(804mg,4mmol),氯化锂(42mg,1mmol),NMP(1mL),反应温度150℃,得到黄色固体334mg,收率65%。MS(EI):m/z(%)=514(100)M+,516(100)M+;1H NMR(400MHz,CDCl3)δ7.80(s,1H,ArH),7.71–7.64(m,1H,ArH),7.56–7.44(m,4H,ArH),6.92(d,J=8.8Hz,1H,ArH),6.80(s,1H,ArH),3.32–3.22(m,1H,CH),1.42(d,J=6.8Hz,6H,2CH3).
实施例30:化合物F15的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),2-甲磺酰胺基苯甲醛(597mg,3mmol),氯化锆(23.3mg,0.1mmol),NMP(6mL),反应温度180℃,得到黄色固体320mg,收率62%。MS(EI):m/z(%)=513(100)M+,515(45)[M+2]+,498(50),434(95),418(80),382(50);1H NMR(400MHz,CDCl3):δ=11.45(brs,1H,NH),7.88-7.83(m,2H,ArH),7.71-7.70(m,1H,ArH),7.56-7.47(m,4H,ArH),7.22-7.21(m,1H,ArH),6.81(s,1H,ArH),3.25(m,1H,CH),2.91(s,3H,CH3),1.42(d,J=6.7Hz,6H,2CH3)。
实施例31:化合物F16的合成
合成方法如实施例16,化合物M5-1(300mg,1mmol),2-对甲苯磺酰胺基苯甲醛(825mg,3mmol),苯硼酸(61mg,0.2mmol),DMF(10mL),反应温度130℃,得到黄色固体333mg,收率60%。MS(EI):m/z(%)=555(36)M+,400(100),384(75);1H NMR(400MHz,CDCl3)δ=11.61(s,1H,NH),7.89–7.71(m,6H,ArH),7.68–7.60(m,1H,ArH),7.44–7.37(m,3H,ArH),7.18–7.12(m,2H,ArH),7.07–7.00(m,2H,ArH),3.38–3.16(m,1H,CH),2.29(s,3H,CH3),1.45(d,J=6.8Hz,6H,2CH3)。
实施例32:化合物F17的合成
合成方法如实施例16,化合物M5-2(317mg,1mmol),2-对甲苯磺酰胺基苯甲醛(1100mg,4mmol),三氟甲磺酸银(25.7mg,0.1mmol),DMF(5mL),反应温度120℃,得到黄色固体315mg,收率55%。MS(EI):m/z(%)=573(25)M+,509(21),418(70),402(77),91(100),65(24);1H NMR(400MHz,CDCl3)δ=11.62(s,1H,NH),7.83(d,J=8.3Hz,1H,ArH),7.76–7.60(m,3H,ArH),7.55–7.44(m,4H,ArH),7.39(t,J=7.8Hz,1H,ArH),7.16–7.04(m,3H,ArH),6.97(s,1H,ArH),3.37–3.22(m,1H,CH),2.29(s,3H,CH3),1.44(d,J=6.8,6H,2CH3)。
实施例33:化合物F18的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),2-对甲苯磺酸酯基苯甲醛(552mg,2mmol),三氟甲磺酸钪(295mg,0..6mmol),DMSO(10mL),反应温度120℃,得到黄色固体383mg,收率65%。MS(EI):m/z(%)=590(100)M+;1H NMR(400MHz,CDCl3)δ8.09(d,J=7.8Hz,1H,ArH),7.64(d,J=7.5Hz,3H,ArH),7.58–7.44(m,5H,ArH),7.40–7.31(m,1H,ArH),7.10(d,J=7.9Hz,2H,ArH),6.77(s,1H,ArH),3.36–3.17(m,1H,CH),2.29(s,3H,CH3),1.43(d,J=6.8Hz,6H,2CH3)。
实施例34:化合物F19的合成
合成方法如实施例16,化合物M5-3(334mg,1mmol),2-(2-萘酰胺基)苯甲醛(933mg,3mmol),醋酸钪(2.2mg,0.01mmol),DMF(1mL),反应温度140℃,得到黄色固体374mg,收率63%。MS(EI):m/z(%)=625(100)M+;1H NMR(400MHz,CDCl3)δ11.80(brs,1H,NH),8.25(s,1H,ArH),7.87(d,J=8.4Hz,1H,ArH),7.84–7.77(m,3H,ArH),7.74–7.68(m,2H,ArH),7.67–7.50(m,5H,ArH),7.44(d,J=8.6Hz,1H,ArH),7.37(t,J=7.8Hz,1H,ArH),7.09(t,J=7.6Hz,1H,ArH),6.85(s,1H,ArH),3.35–3.23(m,1H,CH),1.45(d,J=6.8Hz,6H,2CH3).
四、光谱性质
测试了本发明的全部噻唑[4,5-e]噻吩[2,3-b]吡啶类化合物的光谱学性质,结果表明该类型化合物具有强的固体荧光和液体荧光性能。结果如下表:
从上述结果可以看出本发明的噻唑[4,5-e]噻吩[2,3-b]吡啶类化合物具有强的固体荧光和液体荧光功能,可望在有机光电器件、生物成像和生物传感器等方面有一定的应用。
Claims (4)
1.式(I)所示的噻唑[4,5-e]噻吩[2,3-b]吡啶类化合物:
其中,R选自氢或氯,氟;
R’选自4-羟基或2-羟基,2-甲基,2,6-二甲氧基,2-羟基-5-碘,2-羟基-5-溴,2-羟基-3,5-二叔丁基,2-羟基-4-氰基,2-羟基-4-甲氧基,2-羟基-5-磺酸基,2-氨基,2-甲磺酰胺基,2-对甲基苯磺酰胺基,2-对甲基苯磺酸酯基,2-(萘-2-磺酰胺基),4-苯磺酰基;且R选自氯时,R’不能同时选自4-羟基。
2.式(I)所述的噻唑[4,5-e]噻吩[2,3-b]吡啶类化合物在制备荧光材料中的应用:
其中,R选自氢或氯,氟;
R’选自4-羟基或2-羟基,2-甲基,2,6-二甲氧基,2-羟基-5-碘,2-羟基-5-溴,2-羟基-3,5-二叔丁基,2-羟基-4-氰基,2-羟基-4-甲氧基,2-羟基-5-磺酸基,2-氨基,2-甲磺酰胺基,2-对甲基苯磺酰胺基,2-对甲基苯磺酸酯基,2-(萘-2-磺酰胺基),4-苯磺酰基。
3.权利要求1所述的噻唑[4,5-e]噻吩[2,3-b]吡啶类化合物的制备方法,其特征在于,由以下步骤组成:
(1)以邻位取代的苯甲酰乙腈,异戊醛和硫粉为原料,在碱性条件下,以乙醇作溶剂,在回流状态下反应得到化合物M1;所述邻位取代的苯甲酰乙腈、异戊醛、硫粉、碱的摩尔比为1:1-5:1-5:1-5;邻位取代的苯甲酰乙腈的浓度为1-10mol/L;所述反应式为:
(2)以化合物M1和邻苯二甲酰甘氨酸为原料,以二氯甲烷作溶剂,EDCI和DMAP作脱水剂,在室温条件下反应得到化合物M2;所述化合物M1、邻苯二甲酰甘氨酸、EDCI、DMAP的摩尔比为1:1-5:1-5:1-5;化合物M1的浓度为1-10mol/L;所述反应式为:
(3)化合物M2在水合肼和浓盐酸作用下,以乙醇作溶剂,在0-80℃条件下,脱保护得到化合物M3;所述化合物M2、水合肼、盐酸的摩尔比为1:1-5:1-5;化合物M2的浓度为1-10mol/L;所述反应式为:
(4)化合物M3在酸存在条件下,以醇类化合物作为反应溶剂,回流状态下关环得到化合物M4;所述酸选自盐酸、甲酸或乙酸,醇类溶剂选自甲醇、乙醇或异丙醇;所述化合物M3、酸的摩尔比为1:1-5;化合物M3的浓度为1-10mol/L;所述反应式为:
(5)以化合物M4和五硫化二磷为原料,以甲苯为溶剂,在回流状态下反应得到化合物M5;所述化合物M4、五硫化二磷的摩尔比为1:1-5;化合物M4的浓度为1-10mol/L;所述反应式为:
(6)将化合物M5和芳香醛类化合物,在催化剂存在的条件下,以极性溶剂作为反应溶剂,在80-200℃条件下,反应得到目标化合物F;所述催化剂选自醋酸铜或碘化亚铜、对甲苯磺酸、醋酸钠、氯化锌、三氟甲磺酸锌、硫酸锌、醋酸锌、高氯酸锌、醋酸铑、氯化铈、氯化钇、硫酸锰、氯化锂、氯化锆、苯硼酸、三氟甲磺酸银、三氟甲磺酸钪、醋酸钪;所述极性溶剂选自DMF、DMSO或NMP;所述化合物M5、芳香醛类化合物、催化剂的摩尔比为:1:1-5:0.01-1;化合物M5的浓度为1-10mol/L;所述反应式为:
4.根据权利要求3所述的噻唑[4,5-e]噻吩[2,3-b]吡啶类化合物的制备方法,其特征在于所述步骤(1)的碱选自三乙胺、吡啶或者吗啡啉。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2016100182367 | 2016-01-11 | ||
CN201610018236 | 2016-01-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105777781A CN105777781A (zh) | 2016-07-20 |
CN105777781B true CN105777781B (zh) | 2017-11-10 |
Family
ID=56396025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610217382.2A Active CN105777781B (zh) | 2016-01-11 | 2016-04-08 | 具有荧光功能的噻唑[4,5‑e]噻吩[2,3‑b]吡啶类衍生物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105777781B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106596479B (zh) * | 2016-11-29 | 2019-07-09 | 福州大学 | 一种用于游离氯检测的荧光传感器 |
CN107383057B (zh) * | 2017-07-28 | 2019-04-30 | 中山大学 | 具有固液双荧光功能的咪唑[4,5-e]噻吩[2,3-b]吡啶类衍生物及其制备方法 |
CN111057066B (zh) * | 2019-12-26 | 2021-01-26 | 中山大学 | 红色固体荧光发光材料及其制备方法 |
CN114853783B (zh) * | 2022-05-25 | 2023-05-12 | 中山大学 | 咪唑[4,5-e]噻吩[2,3-b]吡啶并吲哚酮类化合物及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105073756A (zh) * | 2013-02-18 | 2015-11-18 | 国立大学法人九州大学 | 化合物、发光材料及有机发光元件 |
-
2016
- 2016-04-08 CN CN201610217382.2A patent/CN105777781B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105073756A (zh) * | 2013-02-18 | 2015-11-18 | 国立大学法人九州大学 | 化合物、发光材料及有机发光元件 |
Non-Patent Citations (2)
Title |
---|
An arch-bridge-type fluorophore for bridging the gap between aggregation-caused quenching (ACQ) and aggregation-induced emission (AIE);Manna Huang等;《Chem.Sci.》;20160329;第4485-4491页,尤其是Scheme 1,Table 1,FIG1-FIG4 * |
Liye Huang等.A Novel Way to Tricyclic Heteroaromatics;Thiazolo[5,4-b]thieno[3,2-e]pyridine Derivatives.《SYNTHESIS》.2014,第2317-2326页,尤其Scheme 3,表1,第2320右栏至第2325页. * |
Also Published As
Publication number | Publication date |
---|---|
CN105777781A (zh) | 2016-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105777781B (zh) | 具有荧光功能的噻唑[4,5‑e]噻吩[2,3‑b]吡啶类衍生物及其制备方法 | |
Rajguru et al. | Solvent-free, green and efficient synthesis of pyrano [4, 3-b] pyrans by grinding and their biological evaluation as antitumor and antioxidant agents | |
JP6341923B2 (ja) | 強蛍光発光性の複素環化合物及びその製造方法 | |
CN109336860B (zh) | 一种3-甲磺酰基-2-取代苯并噻吩化合物的制备方法 | |
TWI553003B (zh) | 2,6 -雙[3’-(n-咔唑基)苯基] 吡啶類化合物的合成方法 | |
CN108558949A (zh) | 一种用Pd纳米粒子催化合成苯并磷杂环戊二烯的方法 | |
KR102014077B1 (ko) | 신규한 티에노[3,2b]피리딘5(4H)온 유도체 화합물, 이의 제조방법 및 이의 용도 | |
Panahi et al. | A novel donor–π–acceptor halochromic 2, 6-distyrylnaphthalene chromophore: synthesis, photophysical properties and DFT studies | |
Ito et al. | Synthesis and redox behavior of 1, 2-dihydro-1-oxabenz [a] azulen-2-ones | |
CN109879852B (zh) | 一种萘并吡喃枝化三蝶烯类化合物、制备方法及其应用 | |
Chaudhari et al. | Intrinsic catalytic activity of Brønsted acid ionic liquids for the synthesis of triphenylmethane and phthalein under microwave irradiation | |
CN107383057B (zh) | 具有固液双荧光功能的咪唑[4,5-e]噻吩[2,3-b]吡啶类衍生物及其制备方法 | |
Li et al. | Synthesis and spectral properties of carbazole-coumarin hybrid dyes | |
CN107602462B (zh) | 一种制备羟基-2(1h)-喹啉酮的方法 | |
CN102532098B (zh) | 芴及螺芴并噻吩类衍生物及其制备方法 | |
JP6269956B2 (ja) | フリルチアゾール化合物 | |
JP6869524B2 (ja) | アミノベンゾピラノキサンテン系(abpx)色素化合物の製造方法 | |
CN103992298B (zh) | 合成3-苯乙烯基香豆素类化合物的方法 | |
CN104164230B (zh) | 一种近红外有机发光材料的制备方法 | |
Adeloye et al. | 2, 4-Diarylquinolines: Synthesis, absorption and emission properties | |
CN109134342B (zh) | 一种3,4-二取代吡咯的制备方法 | |
CN103664499B (zh) | 并四苯及并五苯类化合物的合成方法 | |
CN107383018B (zh) | 二氢吡嗪并[2,3-b]吲哚、吡嗪并[2,3-b]吲哚类化合物及合成方法和应用 | |
Ikejiri et al. | Synthesis and environment-dependent fluorescence behavior of a biaryl-conjugated (diphenylmethylene) imidazolinone | |
KR20190043743A (ko) | 다이사이안스티릴 벤젠 유도체 및 이를 포함하는 형광재료 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |